Actinium Pharmaceuticals reported $18K in Debt for its fiscal quarter ending in March of 2025.





Debt Change Date
AbbVie USD 72.86B 5.36B Mar/2026
Actinium Pharmaceuticals USD 18K 2K Mar/2025
Amgen USD 57.32B 2.72B Mar/2026
Bioline Rx USD 9.07M 2.31M Mar/2026
Capricor Therapeutics USD 3.38M 0 Mar/2025
Pfizer USD 63.19B 536M Jun/2026